S. Odarchenko

The clinical impact of using complex molecular profiling strategies in routine oncology practice

Helen Sadik, G. Berchem, J. Bellmunt, 2018, Oncotarget.

Efficacy and safety of BCD-021, bevacizumab biosimilar candidate, compared to Avastin: Results of international multicenter randomized double blind phase III study in patients with advanced non-squamous NSCLC.

S. Tjulandin, D. Stroyakovskiy, G. Adamchuk, 2015 .

TOMOTHERAPY IN UKRAINE – GENERAL ANALYSIS OF FIRST TREATMENT RESULTS

S. Odarchenko, K. Gumeniuk, M. Gumeniuk, 2017 .